OryR Is a LuxR-Family Protein Involved in Interkingdom Signaling between Pathogenic Xanthomonas oryzae pv. oryzae and Rice S Ferluga, V Venturi Journal of bacteriology 191 (3), 890-897, 2009 | 119 | 2009 |
A LuxR homologue of Xanthomonas oryzae pv. oryzae is required for optimal rice virulence S Ferluga, J Bigirimana, M Höfte, V Venturi Molecular plant pathology 8 (4), 529-538, 2007 | 107 | 2007 |
The plant pathogen Pseudomonas fuscovaginae contains two conserved quorum sensing systems involved in virulence and negatively regulated by RsaL and the … M Mattiuzzo, I Bertani, S Ferluga, L Cabrio, J Bigirimana, C Guarnaccia, ... Environmental microbiology 13 (1), 145-162, 2011 | 89 | 2011 |
Simultaneous targeting of Eph receptors in glioblastoma S Ferluga, CML Tomé, DM Herpai, R D'Agostino, W Debinski Oncotarget 7 (37), 59860, 2016 | 61 | 2016 |
Proteomic analysis discovers the differential expression of novel proteins and phosphoproteins in meningioma including NEK9, HK2 and SET and deregulation of RNA metabolism J Dunn, S Ferluga, V Sharma, M Futschik, DA Hilton, CL Adams, ... EBioMedicine 40, 77-91, 2019 | 52 | 2019 |
Biological and structural characterization of glycosylation on ephrin-A1, a preferred ligand for EphA2 receptor tyrosine kinase S Ferluga, R Hantgan, Y Goldgur, JP Himanen, DB Nikolov, W Debinski Journal of Biological Chemistry 288 (25), 18448-18457, 2013 | 52 | 2013 |
Structural and functional characterization of monomeric EphrinA1 binding site to EphA2 receptor CML Tomé, E Palma, S Ferluga, WT Lowther, R Hantgan, J Wykosky, ... Journal of Biological Chemistry 287 (17), 14012-14022, 2012 | 37 | 2012 |
Ephs and Ephrins in malignant gliomas S Ferluga, W Debinski Growth Factors 32 (6), 190-201, 2014 | 35 | 2014 |
Global proteome and phospho-proteome analysis of merlin-deficient meningioma and schwannoma identifies PDLIM2 as a novel therapeutic target K Bassiri, S Ferluga, V Sharma, N Syed, CL Adams, E Lasonder, ... EBioMedicine 16, 76-86, 2017 | 34 | 2017 |
Lipopolysaccharide phosphorylation by the WaaY kinase affects the susceptibility of Escherichia coli to the human antimicrobial peptide LL-37 K Bociek, S Ferluga, M Mardirossian, M Benincasa, A Tossi, R Gennaro, ... Journal of Biological Chemistry 290 (32), 19933-19941, 2015 | 32 | 2015 |
N-Acyl Homoserine Lactone Quorum Sensing in Gram-Negative Rhizobacteria S Ferluga, L Steindler, V Venturi Secondary metabolites in soil ecology, 69-90, 2008 | 29 | 2008 |
Constitutive activation of the EGFR–STAT1 axis increases proliferation of meningioma tumor cells S Ferluga, D Baiz, DA Hilton, CL Adams, E Ercolano, J Dunn, K Bassiri, ... Neuro-oncology advances 2 (1), vdaa008, 2020 | 21 | 2020 |
A Rapid Robust Method for Subgrouping Non-NF2 Meningiomas According to Genotype and Detection of Lower Levels of M2 Macrophages in AKT1 E17K Mutated … CL Adams, E Ercolano, S Ferluga, A Sofela, F Dave, C Negroni, ... International Journal of Molecular Sciences 21 (4), 1273, 2020 | 20 | 2020 |
EPHA3 and multi-valent targeting of tumors W Debinski, CL Tome, S Ferluga, PS Sonawane US Patent 10,752,667, 2020 | 1 | 2020 |
BI-09EphA3 RECEPTOR IS A MOLECULAR TARGET EXPRESSED IN MULTIPLE COMPARTMENTS OF GBM S Ferluga, D Gibo, W Debinski Neuro-oncology 16 (Suppl 5), v25, 2014 | 1 | 2014 |
Glycosylation is indispensable for ephrin A1 activity S Ferluga, W Debinski Cancer Research 72 (8_Supplement), 3860-3860, 2012 | 1 | 2012 |
Epha3 and multi-valent targeting of tumors W Debinski, CL Tome, S Ferluga, PS Sonawane US Patent App. 18/316,672, 2023 | | 2023 |
EPHA3 and multi-valent targeting of tumors W Debinski, CL Tome, S Ferluga, PS Sonawane US Patent 11,697,675, 2023 | | 2023 |
miR-9-1 Is a New Circulating Biomarker for Higher-grade Meningioma Regulated via the EGFR-FOS Network D Baiz, C Negroni, S Ferluga, E Ercolano, CL Adams, A Sofela, DA Hilton, ... | | 2020 |
A Rapid Robust Method for Subgrouping Non-NF2 Meningiomas According to Genotype and Detection of Lower Levels of M2 Macrophages in AKT1 E17K Mutated Tumours E Ercolano, S Ferluga, A Sofela, F Dave | | 2020 |